Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study

Open access
Le Treut, Yves Patrice, Grégoire, Emilie, Klempnauer, Jürgen, Belghiti, Jacques, Jouve, Elisabeth, Lerut, Jan, Castaing, Denis, Soubrane, Olivier, Boillot, Olivier, Mantion, Georges, Homayounfar, Kia, Bustamante, Manuel, Azoulay, Daniel, Wolf, Philippe, Krawczyk, Marek, Pascher, Andreas, Suc, Bertrand, Chiche, Laurence, de Urbina, Jorge Ortiz, Mejzlik, Vladimir, Pascual, Manuel, Lodge, J. Peter A., Gruttadauria, Salvatore, Paye, François, Pruvot, François-René, Thorban, Stefan, Foss, Aksel, Adam, René·2013·Annals of Surgery

Abstract

In Brief Objective: The purpose of this study was to assess outcomes and indications in a large cohort of patients who underwent liver transplantation (LT) for liver metastases (LM) from neuroendocrine tumors (NET) over a 27-year period. Background: LT for NET remains controversial due to the absence of clear selection criteria and the scarcity and heterogeneity of reported cases. Methods: This retrospective multicentric study included 213 patients who underwent LT for NET performed in 35 centers in 11 European countries between 1982 and 2009. One hundred seven patients underwent transplantation before 2000 and 106 after 2000. Mean age at the time of LT was 46 years. Half of the patients presented hormone secretion and 55% had hepatomegaly. Before LT, 83% of patients had undergone surgical treatment of the primary tumor and/or LM and 76% had received chemotherapy. The median interval between diagnosis of LM and LT was 25 months (range, 1–149 months). In addition to LT, 24 patients underwent major resection procedures and 30 patients underwent minor resection procedures. Results: Three-month postoperative mortality was 10%. At 5 years after LT, overall survival (OS) was 52% and disease-free survival was 30%. At 5 years from diagnosis of LM, OS was 73%. Multivariate analysis identified 3 predictors of poor outcome, that is, major resection in addition to LT, poor tumor differentiation, and hepatomegaly. Since 2000, 5-year OS has increased to 59% in relation with fewer patients presenting poor prognostic factors. Multivariate analysis of the 106 cases treated since 2000 identified the following predictors of poor outcome: hepatomegaly, age more than 45 years, and any amount of resection concurrent with LT. Conclusions: LT is an effective treatment of unresectable LM from NET. Patient selection based on the aforementioned predictors can achieve a 5-year OS between 60% and 80%. However, use of overly restrictive criteria may deny LT to some patients who could benefit. Optimal timing for LT in patients with stable versus progressive disease remains unclear. This retrospective multicentric study describes a cohort of 213 patients who underwent liver transplantation for neuroendocrine tumors in 35 centers from 11 European countries between 1982 and 2009. Multivariate analysis identified 3 predictors of poor outcome, that is, major resection in addition to transplantation, poor tumor differentiation, and hepatomegaly. Long-term outcome significantly improved over time, in relation with changing patient selection criteria by surgical teams.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e31828ee17c

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 260

Metadata

Authors
Le Treut, Y. P., Grégoire, E., Klempnauer, J., Belghiti, J., Jouve, E., Lerut, J., Castaing, D., Soubrane, O., Boillot, O., Mantion, G., Homayounfar, K., Bustamante, M., Azoulay, D., Wolf, P., Krawczyk, M., Pascher, A., Suc, B., Chiche, L., de Urbina, J. O., Mejzlik, V., Pascual, M., Lodge, J. P. A., Gruttadauria, S., Paye, F., Pruvot, F.-R., Thorban, S., Foss, A., & Adam, R.
Venue
Annals of Surgery
Published
2013-05
Volume
257
Issue
5
Pages
807-815
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2014034361
Cited by
260
References
17
FWCI
14.49
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study. https://app.cochat.ai/papers/10.1097/sla.0b013e31828ee17c
The paper
Le Treut, Y. P., Grégoire, E., Klempnauer, J., Belghiti, J., Jouve, E., Lerut, J., Castaing, D., Soubrane, O., Boillot, O., Mantion, G., Homayounfar, K., Bustamante, M., Azoulay, D., Wolf, P., Krawczyk, M., Pascher, A., Suc, B., Chiche, L., de Urbina, J. O., . . . Adam, R. (2013). Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study. Annals of Surgery. https://doi.org/10.1097/sla.0b013e31828ee17c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.